Kiniksa Pharmaceuticals, Ltd. logo
Kiniksa Pharmaceuticals, Ltd. KNSA
$ 22.59 -1.83%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

Kiniksa Pharmaceuticals, Ltd. Financial Statements 2011-2024 | KNSA

Annual Financial Statements Kiniksa Pharmaceuticals, Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.43 B 868 M 770 M 1.22 B 800 M 904 M - - - - - - -

Shares

70.1 M 69.4 M 68.6 M 61.8 M 54 M 49.5 M - - - - - - -

Historical Prices

20.4 12.5 11.2 19.7 14.7 17.5 - - - - - - -

Net Income

14.1 M 183 M -158 M -161 M -162 M -103 M -64.9 M -24 M - - - - -

Revenue

270 M 220 M 38.5 M - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-25.2 M 9.77 M -157 M -157 M -170 M -108 M -65.4 M - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-22.9 M 12.2 M -154 M -155 M -168 M -108 M -65.4 M -24 M - - - - -

Operating Expenses

- - - - 170 M 108 M - - - - - - -

General and Administrative Expenses

129 M 98 M 85.9 M 45.3 M 35 M 21.6 M 9.04 M 6.56 M - - - - -

All numbers in USD currency

Quarterly Income Statement Kiniksa Pharmaceuticals, Ltd.

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

71.7 M 71 M 70.6 M 70.2 M 69.9 M 69.8 M - 69.4 M 69.3 M 69.1 M - 68.7 M 68.4 M 68.3 M - 66 M 57.9 M 55.3 M - 54.8 M 54.5 M 51.8 M - 48.2 M 18.3 M 2.48 M - 1.94 M 1.67 M - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-12.7 M -3.91 M -17.7 M -13.9 M 15 M -12.3 M - 224 M -20 M -25.2 M - -30.5 M -41.6 M -49.5 M - -43.8 M -37.5 M -26.4 M - -27.1 M -37.2 M -65.8 M - -24.4 M -20.3 M -16 M - -16 M -11.2 M - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

112 M 109 M 79.9 M 67 M 71.5 M 48.3 M - 99.1 M 27 M 32.2 M - 12.1 M 7.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

20.1 M 12.3 M 10.6 M 9.09 M 7.7 M 7.04 M - 6.94 M 5.03 M - - 2.77 M 2.47 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-9.66 M -117 K -16.5 M -10.9 M -3.15 M -11.2 M - 46.4 M -19.4 M -23.3 M - -30.7 M -40.6 M -49.3 M - -43.2 M -31.9 M -29.4 M - -30.4 M -39.3 M -67.6 M - -26.2 M -21.5 M -16.3 M - -16.2 M -11.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-9.57 M 2 K -16.1 M -10.6 M -2.86 M -10.6 M - 46.6 M -19 M -22.7 M - -29 M -40.1 M -49 M - -41.4 M -30.7 M -28.8 M - -29.9 M -38.8 M -67.2 M - -26.1 M -21.5 M -16.3 M - -16.2 M -11.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - 49.3 M - 43.2 M 31.9 M 29.4 M - 30.4 M 39.3 M 67.6 M - 26.2 M 21.5 M 16.3 M - 16.2 M 11.4 M - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

46.4 M 42.4 M 38.7 M 34.5 M 29.2 M 29 M - 24.7 M 23.8 M 22.2 M - 20.8 M 21.8 M 20.6 M - 11.8 M 9.54 M 8.49 M - 8.43 M 8.44 M 8.39 M - 5.52 M 4.33 M 3.71 M - 2.24 M 2.12 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency